When was Mirapex ER approved by the FDA?

Written by Marta Figueiredo, PhD |

A

When was Mirapex ER approved by the FDA?

Category: Mirapex

The U.S. Food and Drug Administration approved Mirapex ER in February 2010 for lessening signs and symptoms of early-stage Parkinson’s disease. That indication was then expanded to also include people with advanced disease. An earlier, immediate-release formulation of the therapy had been approved in 1997, but has since been discontinued.

Marta Figueiredo, PhD avatar

About the Author

Marta Figueiredo, PhD Marta holds a biology degree, a master’s in evolutionary and developmental biology, and a PhD in biomedical sciences from the University of Lisbon, Portugal. She was awarded a research scholarship and a PhD scholarship, and her research focused on the role of several signaling pathways in thymus and parathyroid glands embryonic development. She also previously worked as an assistant professor of an annual one-week embryology course at the University of Lisbon’s Faculty of Medicine.